Atenolol acetate is a derivative of atenolol, a widely used selective β₁-adrenergic receptor blocker prescribed for conditions including hypertension, angina, and post-myocardial infarction care. Atenolol acetate is typically synthesized through enzymatic or chemical acetylation of atenolol. For instance, lipase-catalyzed kinetic resolution has been employed to produce enantiomerically pure (S)-atenolol acetate. This method utilizes Candida rugosa lipase and isopropenyl acetate as the acetylating agent, achieving high enantiomeric excess (ee) values. It is grouped under the following drug class(es): Beta blockers. Its therapeutic use is listed as cardiovascular. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Atenolol monoacetate and 4-[2-(Acetyloxy)-3-[(1-methylethyl)amino]propoxy]benzeneacetamide. Its PubChem CID is 551861.
Atenolol acetate
| CAS No | 250579-95-4 |
|---|---|
| Molecular Formula | C16H24N2O4 |
| Molecular Weight | 308.37 g/mol |
| Synonyms | [1-[4-(2-amino-2-oxoethyl)phenoxy]-3-(propan-2-ylamino)propan-2-yl] acetate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Atenolol acetate is a derivative of atenolol, a widely used selective β₁-adrenergic receptor blocker prescribed for conditions including hypertension, angina, and post-myocardial infarction care.
The listed CAS number is 250579-95-4.
The listed molecular formula is C16H24N2O4.
The listed molecular weight is 308.37 g/mol.
[1-[4-(2-amino-2-oxoethyl)phenoxy]-3-(propan-2-ylamino)propan-2-yl] acetate.
The source lists Atenolol monoacetate and 4-[2-(Acetyloxy)-3-[(1-methylethyl)amino]propoxy]benzeneacetamide.